Abstract
Italy was the first western nation affected by the pandemic and was observed as a pilot case in the management of the new coronavirus epidemic. The outbreak of COVID-19 disease has been challenging in Italy. On June 25, 2020 there were 239,821 total cases, of which 33,592 were deaths nationwide. Three lessons emerged from this experience that can serve as a blueprint to improve future plans for the outbreak of viruses. First, early reports on the spread of COVID-19 can help inform public health officials and medical practitioners in effort to combat its progression; second, inadequate risk assessment related to the urgency of the situation and limited reporting to the virus has led the rapid spread of COVID-19; third, an effective response to the virus had to be undertaken with coherent system of actions simultaneously.
Keywords: COVID-19 pandemic in Italy, first cases, risk assessment, coherent system of actions, lessons learned, human parainfluenza virus (HPIV).
Coronaviruses
Title:Dealing with COVID-19: Lessons Learned from the Italian Experience
Volume: 2 Issue: 1
Author(s): Silvana Mirella Aliberti*, Francesco De Caro, Giovanni Boccia, Rosario Caruso and Mario Capunzo
Affiliation:
- Department of Medicine, Surgery and Dentistry “Scuola Medica Salernitana”, University of Salerno, Fisciano,Italy
Keywords: COVID-19 pandemic in Italy, first cases, risk assessment, coherent system of actions, lessons learned, human parainfluenza virus (HPIV).
Abstract: Italy was the first western nation affected by the pandemic and was observed as a pilot case in the management of the new coronavirus epidemic. The outbreak of COVID-19 disease has been challenging in Italy. On June 25, 2020 there were 239,821 total cases, of which 33,592 were deaths nationwide. Three lessons emerged from this experience that can serve as a blueprint to improve future plans for the outbreak of viruses. First, early reports on the spread of COVID-19 can help inform public health officials and medical practitioners in effort to combat its progression; second, inadequate risk assessment related to the urgency of the situation and limited reporting to the virus has led the rapid spread of COVID-19; third, an effective response to the virus had to be undertaken with coherent system of actions simultaneously.
Export Options
About this article
Cite this article as:
Aliberti Mirella Silvana *, De Caro Francesco, Boccia Giovanni , Caruso Rosario and Capunzo Mario , Dealing with COVID-19: Lessons Learned from the Italian Experience, Coronaviruses 2021; 2 (1) . https://dx.doi.org/10.2174/2666796701999200908094136
DOI https://dx.doi.org/10.2174/2666796701999200908094136 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters COVID-19 and Domestic Animals: Exploring the Species Barrier Crossing, Zoonotic and Reverse Zoonotic Transmission of SARS-CoV-2
Current Pharmaceutical Design Nanomaterial: A Sustainable Way to Fight Against COVID-19
Coronaviruses Can Edible Insects Complement Conventional Livestock? The Desirability of Insect Nutrition for Food Security of a World Heritage Site and Biosphere Reserve
Current Nutrition & Food Science COVID-19: An Update on Clinical Trials
Current Topics in Medicinal Chemistry COVID-19 Improved Diagnoses Based on the Open-morphology Filter and Deep-learning
Recent Patents on Engineering BCG Vaccine, A Ray of Hope in Treating Severe Acute Respiratory Syndrome (SARS)
Infectious Disorders - Drug Targets Understanding the Role of Corona Virus based on Current Scientific Evidence - A Review with Emerging Importance in Pandemic
Recent Patents on Anti-Infective Drug Discovery In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets Impacts of Bioinformatics to Medicinal Chemistry
Medicinal Chemistry Recent Approaches of Repositioning and Traditional Drugs for the Treatment of COVID-19 Pandemic Outbreak
Mini-Reviews in Medicinal Chemistry Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
Current Pharmaceutical Design The Effect of Plant Metabolites on Coronaviruses: A Comprehensive Review Focusing on their IC<sub>50</sub> Values and Molecular Docking Scores
Mini-Reviews in Medicinal Chemistry COVID-19 Impacts, Diagnosis and Possible Therapeutic Techniques: A Comprehensive Review
Current Pharmaceutical Design SARS-CoV-2 & Covid-19: Key-Roles of the ‘Renin-Angiotensin’ System / Vitamin D Impacting Drug and Vaccine Developments
Infectious Disorders - Drug Targets Current Treatments and Therapeutic Options for COVID-19 Patients: A Systematic Review
Infectious Disorders - Drug Targets Perspective on the COVID-19 Coronavirus Outbreak
Combinatorial Chemistry & High Throughput Screening Prediction of Small Molecules Metabolic Pathways Based on Functional Group Composition
Protein & Peptide Letters Comparison of General Dietary and Lifestyle Habits Before and During COVID-19 among the Saudi Adult Population in Riyadh
Current Nutrition & Food Science Therapeutic Management of COVID-19 Patients: Clinical Manifestation and Limitations
Current Pharmaceutical Design